SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG is trending as the community rallies around its position as a Bitcoin-native meme coin within the burgeoning Rune ecosystem. Discussions highlight the strong community, fair distribution, and the potential for $DOG to bridge Bitcoin culture with broader markets through its association with $CBLO. The community emphasizes holding through market volatility.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is trending as traders discuss its potential as a privacy-focused alternative to Bitcoin, drawing comparisons to early BTC gains. Community members are pointing to recent investments from figures like the Winklevoss twins, as well as speculation around institutional adoption and regulatory environments favoring privacy coins. Some traders believe ZEC is inversely correlated to Bitcoin and are closely watching technical patterns for potential breakouts.

Memecoin on Injective taken over by the community.

Nonja

$NONJA is gaining traction as a meme coin on the Injective ($INJ) network, with community members highlighting its strong performance relative to $INJ and its robust, active community.  Discussion revolves around its potential for high returns, especially with the upcoming Injective EVM mainnet and potential ETFs, and the unique qualities of its NFT collections.  The community emphasizes $NONJA's strong fundamentals, burned liquidity, and status as a leading meme coin on the $INJ ecosystem.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as the community discusses potential catalysts including a Wells Fargo upgrade, the possibility of Trump-era tariffs being overturned by the Supreme Court, and a potential boost from a collaboration with SKIMS. Some traders are pointing to technical indicators suggesting a potential breakout, while others express concerns about the company's performance and valuation. Speculation around an upcoming earnings report is also contributing to the heightened interest.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPEV is trending amid discussions about its strategic shift towards AI and robotics, with the unveiling of the 'Iron' humanoid robot driving significant investor interest. The community is actively discussing the potential for XPEV to become a leader in physical AI, expanding beyond its current EV focus, with some comparing it favorably to Tesla. Bullish sentiment is also supported by strong delivery numbers and expansion into new global markets.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

Jumia (JMIA) is trending amid discussions about its Q3 earnings, long-term financial targets presented at its investor day, and a recent fund filing revealing a significant stake. Community members are focused on the company's potential for growth in the African market, its path to profitability, and potential short squeeze opportunities. Bullish sentiment appears to be building around JMIA's position as an uncorrelated asset and its long-term prospects in a growing market.

Cidara Therapeutics, Inc. engages in developing targeted immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases. Its platform, Cloudbreak, enables development of novel drug-Fc conjugates (DFCs) that inhibit specific disease targets while simultaneously engaging the immune system. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Cidara Therapeutics Inc

Cidara Therapeutics is trending due to positive sentiment around a potential acquisition by Merck for $9.2B, which sent the stock soaring. The community is discussing the impact of the deal on options, what happens to shares post-acquisition, and whether a bidding war might further increase the acquisition price. Some investors are also looking at similar companies that may be acquisition targets.

Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.

Tenax Therapeutics Inc

TENX is trending as investors discuss its strong cash position, low share float, and Phase 3 trials targeting a significant patient population. The community is highlighting the potential for a squeeze, drawing comparisons to other stocks with similar ownership structures and catalysts. Some are noting potential institutional interest.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

$BRK.B is trending amid discussions around Warren Buffett's succession and Berkshire Hathaway's massive cash position, leading to speculation about upcoming strategic moves. The community is weighing the impact of Buffett's planned year-end departure and Greg Abel's potential focus on AI and energy sectors. Recent filings revealing new positions, like a stake in Google, and reduced positions in other holdings such as Apple, drive debate on Berkshire's evolving investment strategy.

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Cardinal Health, Inc.

Cardinal Health ($CAH) is trending due to recent analyst upgrades and a positive investor day highlighting growth strategies. Community discussions emphasize the company's potential for margin improvement and long-term value, while others point to an overbought RSI suggesting a possible short-term pullback. The stock is seen as an ole reliable pick in the healthcare distribution sector, with revenue over 200B.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Roth starts on cyber stocks with bullish views on CrowdStrike, CyberArk, Okta

Investing.com -- Roth MKM initiated coverage on several cybersecurity stocks that includes CrowdStrike (NASDAQ:CRWD), CyberArk, Okta (NASDAQ:OKTA), and  SentinelOne  (NYSE:S) at Buy given their strong growth potential and an improving execution across the group.

Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments

Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments PR Newswire VANCOUVER, BC, Dec...

Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend

Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend PR Newswire VANCOUVER, BC, Dec. 2, 2024 USA...

The S&amp;P 500 Index, a broader gauge of stock market performance, finished the week ended Nov. 8 at a record high amid the euphoria over a decisive win for the Republican Party candidate Donald Trump in the 2024 presidential election.The 30-stock Dow Jones Industrial Average and the tech-heavy Nasdaq Composite also ended in uncharted territory.&nbsp;As the new week unfolds, earnings and economic data will once again dictate sentiment. About 91% of the S&amp;P 500 companies have reported already, and the cumulative earnings growth of S&amp;P 500 companies is now estimated at 5.3%,&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://advantage.factset.com/hubfs/Website/Resources%20Section/Research%20Desk/Earnings%20Insight/EarningsInsight_110824.pdf">according</a> to Factset.The first-tier economic data/events for the week include the October consumer and producer price inflation reports, due on Wednesday and Thursday, respectively,&nbsp; the October retail sales report due on Friday and speeches by a slew of Federal Reserve officials.As the new week kickstarts, the following stocks are eliciting the most bullish/bearish reactions from retailers on the Stocktwits platformMost BullishMarathon Digital Holdings, Inc. ($MARA)Bitcoin miner Marathon Digital generated the most bullish sentiment, apparently due to the strength seen in the cryptocurrency space, especially the Bitcoin ($BTC.X). The a<a href="https://stocktwits.com/news-articles/markets/equity/bitcoin-hits-record-high-on-sunday/cJ4gJ3oRax">pex crypto crossed the $80,000 threshold</a> on Sunday and the momentum continued unabated on Monday. Bitcoin rallied past the $81,000 mark early Monday.BlackRock, Inc. ($BLK)Asset manager BlackRock was in the news last Thursday as media reports&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/c811be5f-73aa-4565-8901-f0eacdbad0bc">said</a> the company is in discussions to buy a small equity stake in hedge fund Millennium Management. Millennium is one of the most profitable hedge fund and if the rumors prove to be true, it would mark the first time in the firm’s 35-year history that it is taking an outside investment, Financial Times reportedCoinbase Global, Inc. ($COIN)Cryptocurrency exchange Coinbase may also be riding the crypto strength. In late-October, the company reported an increase in its third-quarter revenue from $623 million in 2023 to $1.13 billion in 2024. But both the earnings per share and revenue trailed expectations due to a muted crypto trading environment.Emergent Biosolutions, Inc. ($EBS)&nbsp;Shares of Emergent Biosolutions, a contract development and manufacturing organization, have picked up some momentum following the company’s quarterly results announced late Wednesday. The stock has tacked on over 31% since then.Netflix, Inc. ($NFLX)Streaming giant Netflix hasn't had any company-specific news or analysts’ action to impact the stock. However, AMC Entertainment Holdings, Inc. ($AMC) said last week its third quarter benefited from a new deal with Netflix for prior seasons of AMC series called the AMC Collection.Most BearishBaidu, Inc. (BIDU)Chinese search giant Baidu drew negative sentiment from retailers. Friday, the stock shed nearly 5% amid muted reaction to additional China stimulus and fears concerning a Trump backlash on overseas companies. Media reports said Baidu will launch its new AI-powered smart glasses at the Baidu World Event in Shanghai on Tuesday. The negative sentiment may also be partly due to investor apprehensions over whether the company can give Meta Platforms, Inc.’s ($META) Ray Ban smart glasses a run for the money.Aurinia Pharmaceuticals, Inc. ($AUPH)Kidney drug company Aurinia failed to attract a buyer after activist hedge fund MKT Capital forced the&nbsp; company to explore strategic initiatives, including a sale. While reporting its financial results last week, the Canadian biotech announced its decision to cut 45% of its workforce in a bid to save cost.Pinduoduo, Inc. ($PDD)General skepticism toward China stocks and domestic competition may have dented sentiment toward Chinese online retailer Pinduoduo.Evolent Health, Inc. ($EVH)Shares of Evolent are languishing at multi-year lows following Friday’s 45%+ plunge in reaction to its lackluster quarterly results. The specialty care management services company that focuses on&nbsp;oncology, cardiology, and musculoskeletal markets in the U.S. was scouting for a buyer earlier this year.Checkpoint Therapeutics, Inc. ($CKPT)Waltham, Massachusetts-based Checkpoint Therapeutics, a clinical-stage,&nbsp;immunotherapy and targeted-oncology company, hasn’t had any stock-moving catalysts.&nbsp;Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/fifth-third-executive-weighs-in-on-election-impact/cJ4ginFRaC">Fifth Third CFO Bryan Preston Sees Trump’s 2024 Presidential Election Win Double-Edged Sword</a>For updates and corrections email newsroom@stocktwits.com&nbsp;

Crypto rally has improved sentiment toward stocks with exposure to them.

10 Stocks Retailers On Stocktwits Are Most Bullish/Bearish About To Start The Week

As the new week unfolds, earnings and economic data will again dictate sentiment. 

Equity

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint...

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Checkpoint Therapeutics, Inc. (CKPT)

The Law Offices of Frank R. Cruz reminds investors of the upcoming June 4, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Checkpoint...

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint PR...

CKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud Lawsuit

CKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud Lawsuit CKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud Lawsuit PR...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CKPT

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CKPT SHAREHOLDER ALERT...

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT ROSEN, A LEADING...

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA.

Checkpoint Therapeutics Inc

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$4.26
Prev Close	$4.23
Open	$4.24
Dividend Yield	0.00%
50-Day Moving Average	$4.11
Beta	0.81
Avg. Volume	2.04M
PE Ratio	-3.78

52-Week High	$4.50
52-Week Low	$1.80
Market Capitalization	$370.71M
EPS (Annual)	-$1.42
Price to Book	21.90
Revenue Per Employee	$1,708.33
Enterprise Value/EBITDA	N/A

CKPT
Checkpoint Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest CKPT News

CKPTCheckpoint Therapeutics Inc